Clinical value of molecular MRD monitoring by next-generation sequencing in patients with IDH2 mutated AML

Evgenii Shumilov,Johanna Flach,Raphael Joncourt,Naomi Porret,Gertrud Wiedemann,Urban Novak,Eva Gfeller,Barbara Jeker,Ursula Amstutz,Thomas Pabst,Ulrike Bacher

Clinical value of molecular MRD monitoring by next-generation sequencing in patients with IDH2 mutated AML

2019

Evgenii Shumilov
Johanna Flach
Raphael Joncourt
Naomi Porret
Gertrud Wiedemann
Urban Novak
Eva Gfeller
Barbara Jeker
Ursula Amstutz
Thomas Pabst
Ulrike Bacher

Considering the expanding therapeutic options for patients with acute myeloid leukemia (AML), minimal residual disease (MRD) diagnostics gain importance for treatment monitoring in this heterogeneo...

Keywords:

Oncology
DNA sequencing
Immunology
IDH2
Medicine
Internal medicine
Diabetes mellitus
in patient
clinical value

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations